US Stock MarketDetailed Quotes

VYGR Voyager Therapeutics

Watchlist
  • 5.780
  • +0.110+1.94%
Close Nov 27 16:00 ET
  • 5.600
  • -0.180-3.11%
Post 20:01 ET
315.74MMarket Cap8.76P/E (TTM)

Voyager Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Voyager Therapeutics Q3 2024 Earnings Date

Currency：USDNov 12, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
11.70M
24.63M
+12.93M
Beat Est.
+153.63%
+433.79%
+110.46%
EPS
-0.44
-0.16
+0.28
Beat Est.
+24.58%
+72.88%
+64.04%
Analyst Rating
Strong Buy

Nov 27, 2024

Voyager Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 7.034M--
--2024/Q4-- / 15.456M--
Nov 12, 20242024/Q324.629M / 11.702M--
Aug 6, 20242024/Q229.578M / 9.514M--
May 13, 20242024/Q119.516M / 9.480M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 7.034M--
--2024/Q4-- / 15.456M--
Nov 12, 20242024/Q324.629M / 11.702M--
Aug 6, 20242024/Q229.578M / 9.514M--
May 13, 20242024/Q119.516M / 9.480M--

Unlock Free Earnings Estimates

Voyager Therapeutics Earnings Reports

  • Voyager Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 12 16:08 ET

  • Voyager Therapeutics | 8-K: Voyager Reports Third Quarter 2024 Financial and Operating Results

    Nov 12 16:04 ET

  • Voyager Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 6 16:06 ET

  • Voyager Therapeutics | 8-K: Voyager Therapeutics Reports Second Quarter 2024 Financial and Operating Results

    Aug 6 16:06 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 27, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data